Literature DB >> 34897715

Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines.

Jeremy Sharib1, Craig L Slingluff2, Georgia M Beasley1.   

Abstract

Since the observation that clearance of all visible and microscopic tumors from cutaneous melanoma is critical to prevent a recurrence, wide surgical margins have been central to surgical dogma. In the last several decades, more conservative margin widths have been vigorously studied by surgical investigators to lessen wound complications, the need for reconstruction, and healthcare costs. This review summarizes surgeon-led clinical trials that define current guidelines and highlights the challenges to initiate and perform trials today.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  clinical trials; margins; melanoma

Mesh:

Year:  2022        PMID: 34897715      PMCID: PMC8682801          DOI: 10.1002/jso.26717

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  19 in total

1.  Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.

Authors:  U Veronesi; N Cascinelli; J Adamus; C Balch; D Bandiera; A Barchuk; R Bufalino; P Craig; J De Marsillac; J C Durand
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

2.  Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

Authors:  Sandra L Wong; Mark B Faries; Erin B Kennedy; Sanjiv S Agarwala; Timothy J Akhurst; Charlotte Ariyan; Charles M Balch; Barry S Berman; Alistair Cochran; Keith A Delman; Mark Gorman; John M Kirkwood; Marc D Moncrieff; Jonathan S Zager; Gary H Lyman
Journal:  Ann Surg Oncol       Date:  2017-12-13       Impact factor: 5.344

3.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

4.  Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.

Authors:  C M Balch; S Soong; M I Ross; M M Urist; C P Karakousis; W J Temple; M C Mihm; R L Barnhill; W R Jewell; H J Wanebo; R Harrison
Journal:  Ann Surg Oncol       Date:  2000-03       Impact factor: 5.344

5.  Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.

Authors:  U Ringborg; R Andersson; J Eldh; B Glaumann; L Hafström; S Jacobsson; P E Jönsson; H Johansson; L Krysander; B Lagerlöf
Journal:  Cancer       Date:  1996-05-01       Impact factor: 6.860

6.  Excision margins in high-risk malignant melanoma.

Authors:  J Meirion Thomas; Julia Newton-Bishop; Roger A'Hern; Gill Coombes; Michael Timmons; Judy Evans; Martin Cook; Jeffery Theaker; Mary Fallowfield; Trevor O'Neill; Wlodek Ruka; Judith M Bliss
Journal:  N Engl J Med       Date:  2004-02-19       Impact factor: 91.245

Review 7.  Surgical excision margins for primary cutaneous melanoma.

Authors:  Michael J Sladden; Charles Balch; David A Barzilai; Daniel Berg; Anatoli Freiman; Teenah Handiside; Sally Hollis; Marko B Lens; John F Thompson
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

8.  Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.

Authors:  C M Balch; M M Urist; C P Karakousis; T J Smith; W J Temple; K Drzewiecki; W R Jewell; A A Bartolucci; M C Mihm; R Barnhill
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

9.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

10.  Facing the NIH funding crisis: how professional societies can help.

Authors:  Robert Hromas; Janis L Abkowitz; Armand Keating
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.